Skip to main content

Table 1 Telephone interview questions discussing the proposed PrEP demonstration project

From: “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria

No. Questiona
1 Have you heard of PrEP before now?
2 What do you know about PrEP?
3 How did you learn about PrEP?
4 Do you think there is any potential positive outcome if Nigeria includes PrEP as part of its HIV-prevention package? What are your concerns?
5 If at the end of the extensive community consultation process there is consensus that PrEP should be implemented in Nigeria, which community do you think should be targeted during the pilot project and why?
6 Do you think we will encounter challenges when discussing PrEP with religious leaders? Why? How do you think we can address this challenge?
7 Do you think we will encounter challenges when discussing PrEP with community leaders? Why? How do you think we can address this challenge?
8 Do you think we will encounter challenges discussing PrEP with PLHIV? Why? How do you think we can address this challenge?
9 Do you think we will encounter challenges discussing PrEP with the community at large? Please could you explain the reason for your perspective? How do you think we can address this challenge?
10 Do you think Nigeria may face challenges in the implementation of PrEP as a HIV-prevention method? Please could you explain the reasons for your response? How do you think we can address this challenge?
11 Finally, is there anything else you would like to share with me about PrEP such as your thoughts, suggestions, queries, concerns, and advice?
  1. aFor questions 1, 4, and 6–10, participants responded as follows: yes, no, or no response. Questions 2, 3, 5, and 11 were open-ended, and respondents were permitted to provide additional comments.
  2. No., number; PrEP, pre-exposure prophylaxis; PLHIV, people living with HIV.